RxDoctor Payments Data

Jonathan Fletcher, PA

Surgical · Baton Rouge, LANPI 1710543822

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (58.6%), food and beverage and education — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Davol Inc. at 39.0% of the total. Reporting peaked in 2024 at $3,038 and has fallen 54.2% since, to $1,390 in 2025. Among surgical clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,428in general payments, 2019–2025

Across 90 payments — averaging $60.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Davol Inc.$2K
  • Intuitive Surgical$1K
  • BD$1K
  • Atricure, Inc.$463
  • Merck$86
  • AstraZeneca$53
  • plus $218 from 10 others

What the payments were for

  • Travel & lodging$3,18059%
  • Food & beverage$2,14840%
  • Education$1002%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,428 in reported general payments places this provider in the 95th percentile of 130 surgical providers in Louisiana.

See all surgical providers in Louisiana

Medicare billing

Part B allowed, 2024
$6,055
Medicare patients
31
Services billed
58

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin11$95
Methocarbamol24$90
Ibuprofen15$65
Tramadol Hcl21$59

Paid to pharmacies, not to this prescriber.

Other surgical in Baton Rouge

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →